These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 36834029)

  • 1. Severity and Outcomes of SARS-CoV-2 Reinfection Compared with Primary Infection: A Systematic Review and Meta-Analysis.
    Deng J; Ma Y; Liu Q; Du M; Liu M; Liu J
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of severe symptomatic laboratory-confirmed SARS-CoV-2 reinfection.
    Murillo-Zamora E; Mendoza-Cano O; Delgado-Enciso I; Hernandez-Suarez CM
    Public Health; 2021 Apr; 193():113-115. PubMed ID: 33774512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, Risk, and Severity of SARS-CoV-2 Reinfections in Children and Adolescents Between March 2020 and July 2022 in Serbia.
    Medic S; Anastassopoulou C; Lozanov-Crvenkovic Z; Dragnic N; Petrovic V; Ristic M; Pustahija T; Tsakris A; Ioannidis JPA
    JAMA Netw Open; 2023 Feb; 6(2):e2255779. PubMed ID: 36780157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reinfection rates among patients previously infected by SARS-CoV-2: systematic review and meta-analysis.
    Mao Y; Wang W; Ma J; Wu S; Sun F
    Chin Med J (Engl); 2022 Jan; 135(2):145-152. PubMed ID: 34908003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
    Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
    PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes associated with SARS-CoV-2 reinfection in individuals with natural and hybrid immunity.
    Suleyman G; Fadel R; Patel K; Shadid AM; Stuart HBC; Kattula M; Janis A; Maki M; Chao S; Alangaden G; Brar I
    J Infect Public Health; 2023 Aug; 16(8):1262-1268. PubMed ID: 37302273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease severity during SARS-COV-2 reinfection: a nationwide study.
    Mensah AA; Lacy J; Stowe J; Seghezzo G; Sachdeva R; Simmons R; Bukasa A; O'Boyle S; Andrews N; Ramsay M; Campbell H; Brown K
    J Infect; 2022 Apr; 84(4):542-550. PubMed ID: 35085659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and outcome of SARS-CoV-2 reinfection in the pre-Omicron era: A global systematic review and meta-analysis.
    Ismail NF; Rahman AE; Kulkarni D; Zhu F; Wang X; Del Carmen Morales G; Srivastava A; Allen KE; Spinardi J; Kyaw MH; Nair H
    J Glob Health; 2023 Nov; 13():06051. PubMed ID: 37994839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Consequences of Asymptomatic SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis.
    Ma Y; Deng J; Liu Q; Du M; Liu M; Liu J
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients.
    Slezak J; Bruxvoort K; Fischer H; Broder B; Ackerson B; Tartof S
    Clin Microbiol Infect; 2021 Dec; 27(12):1860.e7-1860.e10. PubMed ID: 34419576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effectiveness of previous infection against subsequent SARS-Cov-2 infection: systematic review and meta-analysis.
    Hu WH; Cai HL; Yan HC; Wang H; Sun HM; Wei YY; Hao YT
    Front Public Health; 2024; 12():1353415. PubMed ID: 38966699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression.
    Bobrovitz N; Ware H; Ma X; Li Z; Hosseini R; Cao C; Selemon A; Whelan M; Premji Z; Issa H; Cheng B; Abu Raddad LJ; Buckeridge DL; Van Kerkhove MD; Piechotta V; Higdon MM; Wilder-Smith A; Bergeri I; Feikin DR; Arora RK; Patel MK; Subissi L
    Lancet Infect Dis; 2023 May; 23(5):556-567. PubMed ID: 36681084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 Reinfection Has Better Outcomes Than the First Infection in Solid Organ Transplant Recipients.
    Solera JT; Árbol BG; Mittal A; Hall VG; Marinelli T; Bahinskaya I; Humar A; Kumar D
    Transplantation; 2024 May; 108(5):1249-1256. PubMed ID: 38291585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of immune protection of SARS-CoV-2 natural infection against reinfection.
    Chemaitelly H; Nagelkerke N; Ayoub HH; Coyle P; Tang P; Yassine HM; Al-Khatib HA; Smatti MK; Hasan MR; Al-Kanaani Z; Al-Kuwari E; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul-Rahim HF; Nasrallah GK; Al-Kuwari MG; Butt AA; Al-Romaihi HE; Al-Thani MH; Al-Khal A; Bertollini R; Abu-Raddad LJ
    J Travel Med; 2022 Dec; 29(8):. PubMed ID: 36179099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced Odds of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Vaccination Among New York City Adults, July 2021-November 2021.
    Levin-Rector A; Firestein L; McGibbon E; Sell J; Lim S; Lee EH; Weiss D; Geevarughese A; Zucker JR; Greene SK
    Clin Infect Dis; 2023 Feb; 76(3):e469-e476. PubMed ID: 35594552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020-31 January 2023.
    Cegolon L; Magnano G; Negro C; Larese Filon F;
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515237
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study.
    Gazit S; Shlezinger R; Perez G; Lotan R; Peretz A; Ben-Tov A; Herzel E; Alapi H; Cohen D; Muhsen K; Chodick G; Patalon T
    Clin Infect Dis; 2022 Aug; 75(1):e545-e551. PubMed ID: 35380632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Importance and Challenges of Identifying SARS-CoV-2 Reinfections.
    Babiker A; Marvil CE; Waggoner JJ; Collins MH; Piantadosi A
    J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33361342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of reinfection and disease after SARS-CoV-2 primary infection: Meta-analysis.
    Flacco ME; Acuti Martellucci C; Baccolini V; De Vito C; Renzi E; Villari P; Manzoli L
    Eur J Clin Invest; 2022 Oct; 52(10):e13845. PubMed ID: 35904405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study between January, 2020, and July, 2021, in England.
    Mensah AA; Campbell H; Stowe J; Seghezzo G; Simmons R; Lacy J; Bukasa A; O'Boyle S; Ramsay ME; Brown K; Ladhani SN
    Lancet Child Adolesc Health; 2022 Jun; 6(6):384-392. PubMed ID: 35358491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.